Identity
- Trade Name
- REMI FDA UDI
- Generic Name
- Electroencephalographic monitoring system FDA UDI
- Device Name
- REMI Sticker FDA UDI
- Model / Reference
- 20015 FDA UDI
- Description
- REMI Sticker FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00860011072423 FDA UDI
- FDA Product Code
- GXY FDA UDI
- GMDN Term
- Electroencephalographic monitoring system FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 882.1320 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Electroencephalographic monitoring system
Remi by Epitel, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Electroencephalographic monitoring system.
- Pegasus Software License 256ch — NEURALYNX, INC. · Class II
- Pegasus Software License 224ch — NEURALYNX, INC. · Class II
- Enobio Dx — NEUROELECTRICS BARCELONA SL · Class II
- Enobio Dx — NEUROELECTRICS BARCELONA SL · Class II
- Pegasus Software License 416ch — NEURALYNX, INC. · Class II
- ATLAS NK HEADBOX — NEURALYNX, INC. · Class II
- NetCom Client — NEURALYNX, INC. · Class II
- Pegasus Software License 352ch — NEURALYNX, INC. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Epitel, Inc.
Sources (1)
- FDA UDI 207a3f48-52e2-46e1-9893-ba024e0246fb 35 fields · synced May 30, 2026